Literature DB >> 28365943

Papaverine selectively inhibits human prostate cancer cell (PC-3) growth by inducing mitochondrial mediated apoptosis, cell cycle arrest and downregulation of NF-κB/PI3K/Akt signalling pathway.

Hang Huang1, Lin-Jin Li, Hai-Bo Zhang, An-Yang Wei.   

Abstract

PURPOSE: The main objective of the current research work was to investigate the antitumor effects of papaverine in PC-3 human prostate cancer cells along with testing its toxicity in the normal human fibroblast (NHF) cells.
METHODS: The cytotoxic effects of papaverine were examined by the MTT cell viability assay. Flow cytometry using annexin V-FITC/PI was used to study the effects on apoptosis, including its quantification. Effects on cell cycle progression were analyzed by flow cytometry while as effects on apoptosis-related proteins, NF-kB and PI3K/Akt pathways were estimated by Western blot assay.
RESULTS: The results indicated that papaverine could induce significant, highly selective and dose-dependent cytotoxic effects in PC-3 cells without causing too much toxicity in normal cells. Papaverine also led to induction of early and late apoptosis along with inducing sub-G1 cell cycle arrest in a dose-dependent manner. Papaverine induced a dose-dependent reduction in the expression levels of Blc-2 proteins and a dose-dependent increase in the expression levels of Bax protein. The expression levels of NF-kB were decreased markedly in comparison to the untreated control. Papaverine treatment also led to a dose-dependent downregulation of PI3K and phospho-Akt expression.
CONCLUSION: Papaverine showed selective antitumor properties against PC-3 human prostate cancer cells by inducing early and late apoptosis, sub-G1 cell cycle arrest, modulation of apoptosis-related proteins like Bcl-2, Bax, Bid, XIAP and cytochrome C along with downregulation of NFkB, PI3K/Akt signalling pathway.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28365943

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  7 in total

1.  A novel computational approach for drug repurposing using systems biology.

Authors:  Azam Peyvandipour; Nafiseh Saberian; Adib Shafi; Michele Donato; Sorin Draghici
Journal:  Bioinformatics       Date:  2018-08-15       Impact factor: 6.937

2.  In Vitro Effects of Papaverine on Cell Migration and Vascular Endothelial Growth Factor in Cancer Cell Lines.

Authors:  Daniella Anthea Gomes; Anna Margaretha Joubert; Michelle Helen Visagie
Journal:  Int J Mol Sci       Date:  2022-04-22       Impact factor: 6.208

3.  Repurposing Papaverine as an Antiviral Agent against Influenza Viruses and Paramyxoviruses.

Authors:  Megha Aggarwal; George P Leser; Robert A Lamb
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

4.  Anticancer effects of a non-narcotic opium alkaloid medicine, papaverine, in human glioblastoma cells.

Authors:  Mana Inada; Mika Shindo; Kyousuke Kobayashi; Akira Sato; Yohei Yamamoto; Yasuharu Akasaki; Koichi Ichimura; Sei-Ichi Tanuma
Journal:  PLoS One       Date:  2019-05-17       Impact factor: 3.240

5.  Novel Papaverine Metal Complexes with Potential Anticancer Activities.

Authors:  Ahmed Gaber; Walaa F Alsanie; Deo Nandan Kumar; Moamen S Refat; Essa M Saied
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

6.  Grainyhead 1 acts as a drug-inducible conserved transcriptional regulator linked to insulin signaling and lifespan.

Authors:  Giovanna Grigolon; Fabian Fischer; Elisa Araldi; Reto Erni; Jia Yee Wu; Carolin Thomas; Marco La Fortezza; Beate Laube; Doris Pöhlmann; Markus Stoffel; Kim Zarse; Erick M Carreira; Michael Ristow
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

7.  In Vitro Effects of Papaverine on Cell Proliferation, Reactive Oxygen Species, and Cell Cycle Progression in Cancer Cells.

Authors:  Daniella A Gomes; Anna M Joubert; Michelle H Visagie
Journal:  Molecules       Date:  2021-10-22       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.